Improving heart health through nutrition for childhood cancer survivors
Official title: Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
Run by Dana-Farber Cancer Institute · NCT06609473 · Data updated 2026-11-12
This study is testing a nutrition program to see if it can help childhood cancer survivors improve their heart health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 18 Years |
| Sex | All |
| Enrollment | 17 (estimated) |
| Sponsor | Dana-Farber Cancer Institute Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Boston, Massachusetts and 1 other locations) |
| Status | Recruiting |
| Started | April 7, 2025 |
| Main results expected | January 15, 2027 |
| Study ends | June 15, 2028 |
| Registry record updated | September 16, 2026 |
| Trial ID | NCT06609473 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children who have undergone cancer treatment and have one or more cardiovascular risk factors.
✕Probably not a fit
Patients who are not childhood cancer survivors or do not have cardiovascular risk factors may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Cardiovascular Health Equity Through Food (CHEF) program aims to support healthy eating habits among childhood cancer survivors to promote long-term cardiovascular health. This proof-of-concept study will assess the impact of the CHEF intervention on cardiovascular outcomes by collecting data through surveys, interviews, and medical records. Participants will be screened for eligibility and will engage in questionnaires and interviews over a six-month period. The study seeks to identify effective strategies for implementing the intervention in this vulnerable population.
Why it matters
Potential benefit: If successful, this program could significantly improve cardiovascular health outcomes for childhood cancer survivors.
How similar studies have gone: While similar interventions targeting nutrition and health in cancer survivors have shown promise, this specific approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Child with any primary cancer diagnosis (non-relapsed, non-secondary malignancy) who has received cancer-directed therapy that includes chemotherapy and/or radiation therapy; * Child is within one of the following time windows: 1. Among those receiving chemotherapy, any time from start of last planned cycle of chemotherapy until 12 months from completion of chemotherapy; 2. Among those receiving radiation therapy alone or radiation and surgery, any time from completion of radiation until 12 months post completion; * Child has 1 or more cardiovascular risk factor (defined as any of: body mass index ≥ 85th percentile; systolic or diastolic blood pressure ≥90th percentile; dyslipidemia \[triglycerides ≥150 mg/dL, total cholesterol ≥200 mg/dL, LDL cholesterol ≥130 mg/dL, HDL cholesterol ≤40 mg/dL\]; impaired glucose metabolism \[fasting glucose ≥100 mg/dL, hemoglobin A1c ≥5.7%\]; anthracycline exposure ≥100 mg/m2; or any radiation exposure to chest, brain, thoracic spine, or total body); * Child is ≤18 years of age at time of enrollment, or over 18 years of age but under medical guardianship; * Parent/guardian screened positive for food insecurity.\* \*Assessed through validated 2-item food insecurity screen. Exclusion Criteria: * Patient received only surgery, or watchful waiting/surveillance, for cancer- directed therapy; * Foreign national family receiving cancer care as an embassy-pay patient.
Where it's running
-
Boston Children's Hospital
Boston, Massachusetts, United States Recruiting -
Dana-Farber Cancer Institute
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Rahela Aziz-Bose, MD — Dana-Farber Cancer Institute
- Study coordinator: Rahela Aziz-Bose, MD
- Email: rahela_aziz-bose@dfci.harvard.edu
- Phone: 617-632-3352
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Community-led, family-centered communication for Hispanic childhood cancer survivors
This study tests a family-focused communication approach to help young Hispanic adult survivors, their families, and clinicians talk more effectively about survivorship care.
-
SchoolCare uses telepresence robots, school navigation, and teleteaching to keep children with cancer connected to school.
This program will test whether telepresence robots combined with school navigation and teleteaching help children aged 5–17 undergoing cancer treatment stay linked to school and improve attendance, learning, and social well-being.
-
Blood biomarkers for treatment-related brain injury in children with brain tumors
This project will test whether blood plasma biomarkers can show treatment-related brain injury in children with primary brain tumors by comparing those who receive radiotherapy, those who do not, and healthy children of the same age and sex.
-
Mind-body therapies to help anxiety in young cancer survivors
This study tests whether hypnosis and relaxation, added to usual care, can reduce anxiety in children, teens, and young adults who have survived cancer.
-
Pain and sleep problems in children who survived cancer
This study tests how pain and sleep disturbances relate in children who survived cancer compared with healthy peers.
-
At-home light therapy for chemo-related nerve pain in childhood cancer survivors
This study tests whether a six-week at-home light therapy program can help childhood cancer survivors who have chemotherapy-induced peripheral neuropathy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.